Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
Take a look at the companies making news pre-market bell:
— The shares had a slight plunge of 2%, a continuation from last Thursday’s losses, when Nvidia ended the day 3.5% less. This dip followed Tuesday’s brief moment when Nvidia momentarily outshone Microsoft as the most high-priced public company.
— This biopharma stock surged by 37% as the U.S. Food and Drug Administration sanctioned Sarepta’s Elevidys gene therapy for expanded usage to treat Duchenne muscular dystrophy patients. Previously, this therapy was only approved for patients who are able to walk, aged 4 years or older, with fast-track approval for those unable to walk.
— This sports apparel manufacturer saw a 1% rise in shares following an upgrade from Oppenheimer, moving its rating from market perform to outperform. Oppenheimer also reinstated Nike as a key megacap choice, forecasting the stock to recover gradually as the company shifts its attention back to product innovation and brand enhancement.
— Shares rose just over 3% after this software company announced its $150 million share repurchase plan. The firm anticipates this stock buyback scheme to continue until June 30, 2025.
— The pharmaceutical stock gained more than 2.6%, continuing an 8.5% rally from the previous session. It comes after Gilead revealed that their HIV-prevention shot accomplished success in a late-stage trial.
— The online loan marketplace’s shares were slightly down after reports from Bloomberg claimed data stolen from the site is now being auctioned off by hackers. LendingTree had been a cyberattack victim stemming from cloud computing company Snowflake.
— Stock from the iPhone creator inched up following a price hike from Bernstein. Analyst Toni Sacconaghi suggested this optimistic perspective ties with his belief that Apple could lead the artificial intelligence surge, instead of lagging.
— Shares increased 0.7% as news broke on Thursday that the airline declared a 15 cents per share quarterly dividend, a significant 50% leap from previous levels. .
